CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT) (COACT)

September 2, 2022 updated by: Kiyuk Chang, MD,PhD, The Catholic University of Korea
COACT registry is a multicenter registry of consecutive patients undergoing coronary stent implantation at 8 centers in the Catholic University of Korea to evaluate the real world management of patients with coronary artery disease and to assess their in-hospital, medium and long-term outcomes.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

11719

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
      • Daejeon, Korea, Republic of
        • Daejeon St.Mary's Hospital
      • Incheon, Korea, Republic of
        • Incheon St.Mary's Hospital
      • Seoul, Korea, Republic of, 137-701
        • Seoul St.Mary's Hospital
      • Seoul, Korea, Republic of
        • St.Paul's Hospital
      • Seoul, Korea, Republic of
        • Yeouido St.Mary Hospital
    • Gyeonggido
      • Bucheon, Gyeonggido, Korea, Republic of
        • Bucheon St.Mary Hospital
      • Suwon, Gyeonggido, Korea, Republic of
        • St.Vincent's hospital
      • Uijeongbu, Gyeonggido, Korea, Republic of
        • Uijeongbu St.Mary's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

all comers who admitted cardiovascular center for coronary stent implantation

Description

Inclusion Criteria:

  • all consecutive patients who underwent percutaneous coronary intervention
  • written informed consent for the DNA and serum databank

Exclusion Criteria:

  • patients who did not agreed to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
All causes mortality
Time Frame: 6month, each year
6month, each year
Cardiac death
Time Frame: 6 month, each year
6 month, each year
Myocardial infarction
Time Frame: 6 month, each year
6 month, each year
target lesion revascularization
Time Frame: 6 month, each year
6 month, each year
target vessel revascularization
Time Frame: 6 month, each year
6 month, each year

Secondary Outcome Measures

Outcome Measure
Time Frame
non target vessel revascularization
Time Frame: 6 month, each year
6 month, each year
Stent thrombosis
Time Frame: 6 month, each year
6 month, each year
Serum databank for evaluation of biomarkers outcomes
Time Frame: 6 month, each year
6 month, each year
Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes
Time Frame: 6 month, each year
6 month, each year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The Catholic University of Korea

Collaborators

Seoul St. Mary's Hospital
Saint Vincent's Hospital, Korea
Bucheon St. Mary's Hospital
Incheon St.Mary's Hospital
Daejeon St. Mary's hospital
Yeouido St. Mary's Hospital
St.Paul's Hospital, Korea

Investigators

  • Study Chair: Ki-Bae Seung, M.D.,PhD, Seoul St. Mary's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2005

Primary Completion (ACTUAL)

December 1, 2019

Study Completion (ACTUAL)

December 1, 2019

Study Registration Dates

First Submitted

November 12, 2010

First Submitted That Met QC Criteria

November 12, 2010

First Posted (ESTIMATE)

November 15, 2010

Study Record Updates

Last Update Posted (ACTUAL)

September 7, 2022

Last Update Submitted That Met QC Criteria

September 2, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • COACT

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe